Actinium Pharmaceuticals, Inc. — Form D
Actinium Pharmaceuticals, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-31. The offering totals $15.0M, of which $5.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-12-31
- Form: D
- Accession: 0001328440-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $15.0M
- Amount sold: $5.1M
- Remaining: $9.9M
- Minimum investment: $3K
- Investors: 108
- Date of first sale: 2012-12-19
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-189157
Issuer
- Name: Actinium Pharmaceuticals, Inc.
- CIK: 0001328440
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 501 Fifth Avenue, 3rd Floor, New York, NY, 10017
- Phone: 646-459-4201
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Rosemary V Mazanet | Director | New York, NY |
| David V Nicholson | Director | New York, NY |
| Sandesh V Seth | Director | New York, NY |
| Jack V Talley | Director | New York, NY |
| Sergio V Traversa | Director | New York, NY |
| Dragan V Cicic | Executive Officer | New York, NY |
| Enza V Guagenti | Executive Officer | New York, NY |
| Jack V Talley | Executive Officer | New York, NY |
| David Nicholson | Director | Carlsbad, CA |
| Richard Sherman | Director | Kilauea, HI |
| Richard Sherman | Executive Officer | Kilauea, HI |
| Rosemary Mazanet | Director | Newark, NJ |
| Dragan Cicic | Director | Newark, NJ |
| Dragan Cicic | Executive Officer | Newark, NJ |
Other filings by this issuer (2)
More